Skip to content

European Multicentre Tics in Children Study

European Multicentre Tics in Children Study - EMTICS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40209
Enrollment
70
Registered
2013-08-08
Start date
2014-01-29
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tourette's disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: ONSET Study: 1. First degree relative of person with TS or another chronic tic disorder according to DSM IV-TR criteria (American Psychiatric Association) 2. Aged 3-10 years, male or female COURSE STUDY: 1. Having TS or another chronic tic disorder according to DSM IV-TR criteria (American Psychiatric Association) 2. Age 3-16 years, male or female;Parents and patients have provided written informed consent and assent as appropriate according to ethical regulation

Exclusion criteria

Exclusion criteria: ONSET: 1. Presence of tics 2. Presence of OCD 3. Serious medical illness 4. Child treated with antibiotics in the past 1 month. 5. Children and/or parents are unable to understand and comply with protocol. COURSE: 1. Serious medical illness 2. Child treated with antibiotics in the past 1 month. 3. Children and/or parents are unable to understand and comply with protocol

Design outcomes

Primary

MeasureTime frame
The main study outcome is onset of tics (ONSET study) and tic exacerbations (COURSE study), as assessed by the Yale Global tic severity scale (YGTSS) plus Premonitory Urge for Tics Scale (PUTS).

Secondary

MeasureTime frame
Other main parameters are the presence of obsessive-compulsive symptoms as assessed by the Children*s Yale Brown Obsessive-Compulsive Scale (CY-BOCS) and the presence of GAS in throat swabs.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)